These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 11623946)
1. Anton J. Carlson: witness for the prosecution. Young JH Pharm Hist; 1999; 41(2):47-51. PubMed ID: 11623946 [No Abstract] [Full Text] [Related]
2. Social Medicine, Medical Economics and Miscellany. JAMA; 2019 Sep; 322(11):1111. PubMed ID: 31528997 [No Abstract] [Full Text] [Related]
3. The Federal Food and Drug Administration in the United States: born and bred in crises. Taylor WJ Int J Clin Pharmacol; 1973 Apr; 7(2):156-62. PubMed ID: 4581340 [No Abstract] [Full Text] [Related]
4. Adequate controls for new drugs: good manufacturing practice and the 1938 federal Food, Drug, and Cosmetic Act. Cooper DE Pharm Hist; 2002; 44(1):12-23. PubMed ID: 12068915 [No Abstract] [Full Text] [Related]
5. Drug abuse control under FDA, 1938-1968. Swann JP Public Health Rep; 1997; 112(1):83-6. PubMed ID: 9018295 [No Abstract] [Full Text] [Related]
6. Invisible monuments and the costs of pharmaceutical regulation: twenty-five years of drug lag debate. Daemmrich A Pharm Hist; 2003; 45(1):3-17. PubMed ID: 12691078 [No Abstract] [Full Text] [Related]
7. A century of ensuring safe foods and cosmetics. Meadows M FDA Consum; 2006; 40(1):6-13. PubMed ID: 16528821 [No Abstract] [Full Text] [Related]
8. The FDA's regulation and control of antibiotics in the 1950s: the Henry Welch scandal, Félix Martí-Ibáñez, and Charles Pfizer & Co. McFadyen RE Bull Hist Med; 1979; 53(2):159-69. PubMed ID: 389316 [No Abstract] [Full Text] [Related]
9. The Atlanta Falcon and Tono-Bungay: dietary supplements as subprime drugs. Weissmann G FASEB J; 2009 May; 23(5):1279-82. PubMed ID: 19406845 [No Abstract] [Full Text] [Related]
10. The 1941 sulfathiazole disaster and the birth of good manufacturing practices. Swann JP Pharm Hist; 1999; 41(1):16-25. PubMed ID: 11623769 [No Abstract] [Full Text] [Related]
11. Federal drug and narcotic legislation. Young JH Pharm Hist; 1995; 37(2):59-67. PubMed ID: 11639645 [No Abstract] [Full Text] [Related]
12. Two centuries of assessing drug risks. Avorn J N Engl J Med; 2012 Jul; 367(3):193-7. PubMed ID: 22808954 [No Abstract] [Full Text] [Related]
13. Fifty years of cosmetic safety: a government and industry partnership. Donegan TJ Food Drug Law J; 1995; 50 Spec():151-62. PubMed ID: 10343040 [No Abstract] [Full Text] [Related]
14. Alternative drugs: homeopathy, Royal Copeland, and federal drug regulation. White Junod S Pharm Hist; 2000; 42(1-2):13-35. PubMed ID: 11624552 [No Abstract] [Full Text] [Related]
15. The FDA at work: cutting-edge science promoting public health. Hilts PJ FDA Consum; 2006; 40(1):28-35, 39-41. PubMed ID: 16528824 [No Abstract] [Full Text] [Related]
16. The goose that laid the golden capsule, part I. Smith BE Tenn Med; 2005 May; 98(5):224-5. PubMed ID: 15934531 [No Abstract] [Full Text] [Related]
17. Johnny's in the basement, mixin' up the medicine. Review of Angell, Avorn, and Daemmrich on the modern pharmaceutical predicament. Mirowski P Soc Stud Sci; 2007 Apr; 37(2):311-27. PubMed ID: 17645149 [No Abstract] [Full Text] [Related]
19. An alternative perspective: homeopathic drugs, Royal Copeland, and federal drug regulation. Junod SW Food Drug Law J; 2000; 55(1):161-83. PubMed ID: 12375600 [No Abstract] [Full Text] [Related]
20. Senator Royal Copeland. The medical and political career of a homeopathic physician. Davidson JR; Dantas F Pharos Alpha Omega Alpha Honor Med Soc; 2008; 71(3):4-10. PubMed ID: 18767595 [No Abstract] [Full Text] [Related] [Next] [New Search]